{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:24:58Z","timestamp":1790760298570,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["762285"],"award-info":[{"award-number":["762285"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CF2019-53358"],"award-info":[{"award-number":["CF2019-53358"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bcp.2021.114845","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T10:50:10Z","timestamp":1637232610000},"page":"114845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma"],"prefix":"10.1016","volume":"195","author":[{"given":"Linda Vanessa","family":"M\u00e1rquez-Quiroga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Arellanes-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Roc\u00edo","family":"V\u00e1squez-Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2021.114845_b0005","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bcp.2021.114845_b0010","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"S1","key":"10.1016\/j.bcp.2021.114845_b0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/liv.14362","article-title":"Natural history of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","article-title":"Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?","volume":"29","author":"Febbraio","year":"2019","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/febs.14209","article-title":"Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes","volume":"285","author":"Ma","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2021.114845_b0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114845_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ccr.2008.06.016","article-title":"Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis","volume":"14","author":"Sakurai","year":"2008","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bcp.2021.114845_b0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01297150","article-title":"Hepatocyte proliferation in stepwise development of experimental liver cell cancer","volume":"36","author":"Farber","year":"1991","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0050","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/hep.31391","article-title":"Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma","volume":"73","author":"Hall","year":"2021","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.bcp.2021.114845_b0055","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/febs.13681","article-title":"Lipid desaturation - the next step in targeting lipogenesis in cancer?","volume":"283","author":"Peck","year":"2016","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-016-0146-8","article-title":"Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments","volume":"4","author":"Peck","year":"2016","journal-title":"Cancer Metab."},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.bcp.2021.114845_b0075","series-title":"Encyclopedia of Toxicology","first-page":"402","article-title":"Streptozotocin","author":"Abdollahi","year":"2014"},{"issue":"6","key":"10.1016\/j.bcp.2021.114845_b0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol. Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114845_b0085","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diab.43.11.1326","article-title":"STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells","volume":"43","author":"Schnedl","year":"1994","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2021.114845_b0090","first-page":"2327","article-title":"IL-27 Inhibits Hyperglycemia and Pancreatic Islet Inflammation Induced by Streptozotocin in Mice","volume":"179","author":"Fujimoto","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114845_b0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00125-011-2365-4","article-title":"Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice","volume":"55","author":"Takeda","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.bcp.2021.114845_b0100","first-page":"2786","article-title":"Alkylation of DNA in rat tissues following administration of streptozotocin","volume":"41","author":"Bennett","year":"1981","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114845_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01209729","article-title":"Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis","volume":"14","author":"Morgan","year":"1994","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/bchm3.1995.376.3.179","article-title":"Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage","volume":"376","author":"Kr\u00f6ncke","year":"1995","journal-title":"Bio. Chem. Hoppe-Seyler"},{"issue":"2","key":"10.1016\/j.bcp.2021.114845_b0115","first-page":"60","article-title":"Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats","volume":"45","author":"West","year":"1996","journal-title":"The West Indian Med. J."},{"issue":"11","key":"10.1016\/j.bcp.2021.114845_b0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/diab.23.11.889","article-title":"Diabetogenic effect of streptozotocin in the rat during the perinatal period","volume":"23","author":"Portha","year":"1974","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2021.114845_b0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/diab.32.5.445","article-title":"Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas","volume":"32","author":"Giroix","year":"1983","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0130","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1038\/s41598-020-64902-8","article-title":"Pemafibrate, a selective PPAR\u03b1 modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content","volume":"10","author":"Sasaki","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2021.114845_b0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.33549\/physiolres.933592","article-title":"Pathophysiological analysis of the progression of hepatic lesions in STAM mice","volume":"66","author":"Saito","year":"2017","journal-title":"Physiol. Res"},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1538\/expanim.18-0152","article-title":"Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice","volume":"68","author":"Iida","year":"2019","journal-title":"Exp. Anim."},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0145","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit. Rev. Immunol."},{"issue":"3-4","key":"10.1016\/j.bcp.2021.114845_b0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10520290802451085","article-title":"Immunohistochemistry in the evaluation of neovascularization in tumor xenografts","volume":"83","author":"Wang","year":"2008","journal-title":"Biotech. Histochem."},{"issue":"23","key":"10.1016\/j.bcp.2021.114845_b0160","doi-asserted-by":"crossref","first-page":"10839","DOI":"10.18632\/aging.102488","article-title":"HIF-2\u03b1 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway","volume":"11","author":"Chen","year":"2019","journal-title":"Aging"},{"issue":"6","key":"10.1016\/j.bcp.2021.114845_b0165","first-page":"2256","article-title":"The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice","volume":"44","author":"Fishman","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2021.114845_b0170","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/cas.12498","article-title":"Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis","volume":"105","author":"Takaki","year":"2014","journal-title":"Cancer Sci."},{"issue":"22","key":"10.1016\/j.bcp.2021.114845_b0175","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1158\/0008-5472.CAN-19-1277","article-title":"HNF4\u03b1-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma","volume":"79","author":"Fekry","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0180","doi-asserted-by":"crossref","first-page":"17257","DOI":"10.1038\/s41598-018-35653-4","article-title":"BET Inhibition Improves NASH and Liver Fibrosis","volume":"8","author":"Middleton","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2021.114845_b0185","first-page":"1707","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov."},{"issue":"5","key":"10.1016\/j.bcp.2021.114845_b0190","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ijc.23995","article-title":"Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats","volume":"124","author":"Wang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114845_b0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","article-title":"N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation","volume":"71","author":"Verna","year":"1996","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","article-title":"Epidemiology of hepatocellular carcinoma","volume":"24","author":"Lafaro","year":"2015","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114845_b0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(03)00097-6","article-title":"Environmental persistence of chemicals and their carcinogenic risks to humans","volume":"528","author":"Pollack","year":"2003","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2018.06.009","article-title":"Mutational landscape of a chemically-induced mouse model of liver cancer","volume":"69","author":"Connor","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","article-title":"Model of nonalcoholic steatohepatitis","volume":"79","author":"Lieber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"247","key":"10.1016\/j.bcp.2021.114845_b0225","article-title":"High-Fat Diet Promotes Macrophage-Mediated Hepatic Inflammation and Aggravates Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice","volume":"7","author":"Fu","year":"2020","journal-title":"Front. Nutr."},{"issue":"13","key":"10.1016\/j.bcp.2021.114845_b0230","first-page":"3473","article-title":"p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein\/extracellular signal-regulated kinase kinase1,2","volume":"63","author":"Li","year":"2003","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2021.114845_b0235","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/cncr.11425","article-title":"Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma","volume":"97","author":"Iyoda","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2021.114845_b0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbi.2019.02.024","article-title":"Diethylnitrosamine enhances hepatic tumorigenic pathways in mice fed with high fat diet (Hfd)","volume":"303","author":"Arboatti","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12876-014-0195-9","article-title":"High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma","volume":"14","author":"Duan","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114845_b0250","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ng1481","article-title":"Application of comparative functional genomics to identify best-fit mouse models to study human cancer","volume":"36","author":"Lee","year":"2004","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2021.114845_b0255","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC","volume":"130","author":"Calvisi","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","article-title":"Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine","volume":"16","author":"Kishida","year":"2016","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bcp.2021.114845_b0265","series-title":"Magnetic Resonance Spectroscopy","first-page":"104","article-title":"Chapter 2.3-The Biochemistry of Choline","author":"Lin","year":"2014"},{"issue":"2","key":"10.1016\/j.bcp.2021.114845_b0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1123\/ijsnem.18.2.191","article-title":"Choline: an important micronutrient for maximal endurance-exercise performance?","volume":"18","author":"Penry","year":"2008","journal-title":"Int. J Sport Nutr. Exerc. Metab."},{"issue":"6","key":"10.1016\/j.bcp.2021.114845_b0275","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114845_b0280","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3748\/wjg.v12.i12.1905","article-title":"Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats","volume":"12","author":"de Oliveira","year":"2006","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bcp.2021.114845_b0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S0100-879X2006000200004","article-title":"Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease","volume":"39","author":"Oliveira","year":"2006","journal-title":"Braz. J Med. Biol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114845_b0290","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2008.07.024","article-title":"A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma","volume":"49","author":"de Lima","year":"2008","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114845_b0295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1582-4934.2002.tb00518.x","article-title":"Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet","volume":"6","author":"Oliveira","year":"2002","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114845_b0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12876-020-01467-w","article-title":"Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)\/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"1_suppl","key":"10.1016\/j.bcp.2021.114845_b0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab. Anim."},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0315","doi-asserted-by":"crossref","first-page":"e0244763","DOI":"10.1371\/journal.pone.0244763","article-title":"Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales","volume":"16","author":"Carter","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2021.114845_b0320","doi-asserted-by":"crossref","unstructured":"G. Zhang, X. Wang, T.-Y. Chung, W. Ye, L. Hodge, L. Zhang, K. Chng, Y.-F. Xiao, Y.J. Wang, Carbon tetrachloride (CCl(4)) accelerated development of non-alcoholic fatty liver disease (NAFLD)\/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF), BMC Gastroenterol. 20 (1) (2020) 339-339.","DOI":"10.1186\/s12876-020-01467-w"},{"issue":"1","key":"10.1016\/j.bcp.2021.114845_b0325","doi-asserted-by":"crossref","first-page":"19601","DOI":"10.1038\/s41598-019-56039-0","article-title":"Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis","volume":"9","author":"Asakawa","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:09:35Z","timestamp":1762096175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":65,"alternative-id":["S0006295221004615"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114845","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114845"}}